These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15222495)

  • 41. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists.
    Conlin PR
    Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventing vascular events due to elevated blood pressure.
    Yusuf S
    Circulation; 2006 May; 113(18):2166-8. PubMed ID: 16684871
    [No Abstract]   [Full Text] [Related]  

  • 44. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
    [No Abstract]   [Full Text] [Related]  

  • 45. [Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)].
    Scholze J; Müller U
    MMW Fortschr Med; 2006 Oct; 148(42):48. PubMed ID: 17621800
    [No Abstract]   [Full Text] [Related]  

  • 46. Antihypertensive treatment, myocardial infarction, and nocturnal myocardial ischaemia.
    Floras JS
    Lancet; 1988 Oct; 2(8618):994-6. PubMed ID: 2902496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 48. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal.
    Zanchetti A; Grassi G; Mancia G
    J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized clinical trials: prescriptions to be applied with caution!
    Alderman MH
    Am J Hypertens; 2008 May; 21(5):483-4. PubMed ID: 18437132
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hypertension in the elderly].
    Plouin PF; Rossignol P; Bobrie G
    Bull Acad Natl Med; 2006; 190(4-5):793-805; discussion 806, 873-6. PubMed ID: 17195607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Antihypertensive therapy: campaign of the giants].
    Füessl HS
    MMW Fortschr Med; 2005 Dec; 147(51-52):28. PubMed ID: 16402700
    [No Abstract]   [Full Text] [Related]  

  • 53. [New tendencies in combination antihypertensive therapy].
    van der Giet M; Paul M
    MMW Fortschr Med; 2005 Nov; 147(46):44-6. PubMed ID: 16358634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Threshold and target blood pressures for treating hypertension. The facts].
    Holzgreve H
    MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of additional antihypertensive medications in patients with high-risk hypertension: a post hoc analysis of the SPRINT (Systolic Blood Pressure Intervention Trial) database.
    Nguyen LS
    J Clin Hypertens (Greenwich); 2018 Apr; 20(4):814-815. PubMed ID: 29542858
    [No Abstract]   [Full Text] [Related]  

  • 56. [The hypotensive effect of prazosin].
    Huysmans FT; Thien T; Rosier JG; van't Laar A; Koene RA
    Ned Tijdschr Geneeskd; 1980 Jul; 124(28):1141-7. PubMed ID: 7402391
    [No Abstract]   [Full Text] [Related]  

  • 57. You should treat patients over the age of 80 who have hypertension.
    Lundberg GD
    Medscape J Med; 2008; 10(8):185. PubMed ID: 18924637
    [No Abstract]   [Full Text] [Related]  

  • 58. Implications and controversies of recent hypertension trials.
    Schwartz ML
    J Am Coll Cardiol; 2006 Aug; 48(4):848-9; author reply 849-50. PubMed ID: 16904567
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of hypertension: how low should the pressure be?].
    de Leeuw PW
    Ned Tijdschr Geneeskd; 1988 May; 132(21):948-50. PubMed ID: 3374690
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.